Clinical Trial: A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07494409) titled 'A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia' on March 20.

Brief Summary: This is a phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in anemic patients with End-Stage-Kidney-Disease (ESKD)

Study Start Date: Oct. 31, 2025

Study Type: INTERVENTIONAL

Condition: Anemia Due to Chronic Kidney Disease

Intervention: DRUG: AND017 capsules

AND017 capsules administered orally with a starting dose of 10 mg TIW

DRUG: ESA

ESA injection and dose based on package insert and local practice

Recruitment Sta...